Sundaram Multi Pap Q1 FY27 Standalone Revenue at ₹49.7 Crore, Net Profit ₹0.3 Crore
Sundaram Multi Pap Limited reported Q1 FY27 unaudited standalone results. Total income was ₹49.71 crore. Net profit after tax was ₹0.32 crore. EPS stood at ₹0.01. The results were approved by the Board on August 13, 2026.
The financial results are not significantly positive or negative, and the profit figures are relatively small, suggesting a low impact on the stock.
The results show a significant decrease in net profit compared to the previous quarter, although it is an improvement from the loss in the same quarter last year. The overall financial performance is neutral.
Sundaram Multi Pap Limited has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company reported a total income from operations (net) of ₹4,970.52 lacs (₹49.71 crore) for the quarter.
The net profit for the period after tax stood at ₹31.81 lacs (₹0.32 crore). This compares to a net profit of ₹117.34 lacs (₹1.17 crore) in the preceding quarter (ended March 31, 2026) and a loss of ₹44.38 lacs (₹0.44 crore) in the corresponding quarter of the previous year (ended June 30, 2025).
Total comprehensive income for the period after tax was ₹31.37 lacs (₹0.31 crore). The company's equity share capital remained stable at ₹4,738.78 lacs (₹47.39 crore). Earnings per equity share (EPS) for basic and diluted were ₹0.01 for the quarter ended June 30, 2026.
The Board of Directors approved these results on August 13, 2026. The detailed financial results have been published in the Free Press Journal and Nav Shakti and are also available on the websites of the BSE, NSE, and the company.
What to do with a filing like this
Sundaram Multi Pap Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sundaram Multi Pap Limited. Read the original for the full detail.